Key market opportunities in AI for omics studies include the demand for precision medicine, adoption of AI in drug discovery, and AI-powered multi-omics data integration. Emphasis on personalized ...

Dr. Dr. Ahmad Aziz, a scientist at DZNE's Bonn site, has been awarded a „Proof of Concept Grant“ from the European Research Council (ERC). He aims to further develop innovative software for analyzing ...

Responses to prescribed medication may vary due to genetic differences. Yet, surprisingly little is known about genetic regulatory mechanisms that underly complex traits and diseases in humans. A ...

AI coding benchmark MirrorCode published its full results June 26, showing Claude Opus 4.7 autonomously rebuilt a 60,000-line interpreter and scored 56% overall — completing tasks that take human ...

Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on ...

There's a BEACON of hope for kids with cancer, as data specialists at Hudson Institute of Medical Research embark on an ...

Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated ...

The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...

Kiran Veernapu has spent more than 25 years building the data systems that large organizations rely on to make decisions. His ...

The NIMML Institute ("NIMML"), a 501 (c)(3) nonprofit research institute dedicated to the discovery of novel precision medicines for infectious, inflammatory and autoimmune diseases, today announced ...

Nature’s Ark, has developed two mobile Android apps — iButterfly Explorer and iBiodiversity Count — specifically targeted at ...

Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...